Altoida
Latest round
- Series A
Last raised
- Mar 2022
Total raised
- $21M
Investors
- 10
About Altoida
Founded in 2016 and based in the District of Columbia, US, Altoida, Inc. operates as a precision neurology company. The company was founded by its CSO, Ioannis Tarnanas. In March 2022, Altoida, Inc. at USD 60 million post-money. Altoida develops digital biomarkers for neurological diseases. The company offers a precision neurology platform, which is a tablet-based digital biomarker platform that uses augmented reality (AR) and machine learning to capture deficits associated with Alzheimer's disease and other neurogenerative conditions at their earliest stages. The platform analyzes users' movements, reaction times, and navigation through these tasks to generate digital biomarkers.
Who invested in Altoida
10 investors across 4 rounds
See all investors in Altoida
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Altoida
Who invested in Altoida?
Altoida has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Altoida raised?
Altoida has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Altoida last raise money?
Altoida's most recent round on record is a Series A, in Mar 2022.
What does Altoida do?
Founded in 2016 and based in the District of Columbia, US, Altoida, Inc.
Where is Altoida headquartered?
Altoida is headquartered in Washington, US.
Which VCs invest in companies like Altoida?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Altoida's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Altoida? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.